KROS icon

Keros Therapeutics
KROS

Overview Fund Trends Analyst Outlook Journalist POV

51 hedge funds and large institutions have $410M invested in Keros Therapeutics in 2020 Q2 according to their latest regulatory filings, with 51 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
51
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$70.3M
2
+$63M
3
+$53.6M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$51M
5
VA
VR Adviser
New York
+$25.2M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$420K
27
$394K
28
$390K
29
$351K
30
$328K
31
$294K
32
$240K
33
$236K
34
$229K
35
$160K
36
$153K
37
$143K
38
$132K
39
$98.7K
40
$88K
41
$83K
42
$81K
43
$67K
44
$47K
45
$42K
46
$35K
47
$34K
48
$23K
49
$19K
50
$13K
1
2
3